Literature DB >> 19543482

Quantification of hormesis in anticancer-agent dose-responses.

Marc A Nascarella1, Edward J Stanek, George R Hoffmann, Edward J Calabrese.   

Abstract

Quantitative features of dose responses were analyzed for 2,189 candidate anticancer agents in 13 strains of yeast (Saccharomyces cerevisiae). The agents represent a diverse class of chemical compounds including mustards, other alkylating agents, and antimetabolites, inter alia. Previous analyses have shown that the responses below the toxic threshold were stimulatory and poorly predicted by a threshold dose-response model, while better explained by a hormetic dose-response model. We determined the quantitative features of the hormetic concentration-responses (n = 4,548) using previously published entry and evaluative criteria. The quantitative features that are described are: (1) the width of the concentration range showing stimulation above 10% of the control (mean of 5-fold), (2) the maximum stimulation of the concentration-responses (mean of 27% above the control), and (3) the width from the maximum stimulation to the toxicological threshold (mean of 3.7-fold). These results show that 52.5% of the 2,189 chemicals evaluated display hormetic concentration-responses in at least one of the 13 yeast strains. Many chemicals showed hormesis in multiple strains, and 24 agents showed hormesis in all 13 strains. The data are compared to previously reported quantitative features of hormesis based on published literature.

Entities:  

Keywords:  anti-tumor; biphasic; hormesis; low-dose; threshold; yeast

Year:  2009        PMID: 19543482      PMCID: PMC2695573          DOI: 10.2203/dose-response.08-025.Nascarella

Source DB:  PubMed          Journal:  Dose Response        ISSN: 1559-3258            Impact factor:   2.658


  10 in total

Review 1.  Overcompensation stimulation: a mechanism for hormetic effects.

Authors:  E J Calabrese
Journal:  Crit Rev Toxicol       Date:  2001-07       Impact factor: 5.635

2.  Defining hormesis.

Authors:  E J Calabrese; L A Baldwin
Journal:  Hum Exp Toxicol       Date:  2002-02       Impact factor: 2.903

Review 3.  The occurrence of hormetic dose responses in the toxicological literature, the hormesis database: an overview.

Authors:  Edward J Calabrese; Robyn Blain
Journal:  Toxicol Appl Pharmacol       Date:  2005-02-01       Impact factor: 4.219

Review 4.  Drug development and hormesis: changing conceptual understanding of the dose response creates new challenges and opportunities for more effective drugs.

Authors:  Edward J Calabrese; John W Staudenmayer; Edward J Stanek
Journal:  Curr Opin Drug Discov Devel       Date:  2006-01

5.  Hormesis outperforms threshold model in National Cancer Institute antitumor drug screening database.

Authors:  Edward J Calabrese; John W Staudenmayer; Edward J Stanek; George R Hoffmann
Journal:  Toxicol Sci       Date:  2006-09-01       Impact factor: 4.849

6.  Hormesis at the National Toxicology Program (NTP): Evidence of Hormetic Dose Responses in NTP Dose-Range Studies.

Authors:  Edward J Calabrese; Linda A Baldwin
Journal:  Nonlinearity Biol Toxicol Med       Date:  2003-10

7.  A model of two functionally antagonistic receptor populations activated by the same agonist.

Authors:  E Szabadi
Journal:  J Theor Biol       Date:  1977-11-07       Impact factor: 2.691

Review 8.  Cancer biology and hormesis: human tumor cell lines commonly display hormetic (biphasic) dose responses.

Authors:  Edward J Calabrese
Journal:  Crit Rev Toxicol       Date:  2005-07       Impact factor: 5.635

9.  Hormesis predicts low-dose responses better than threshold models.

Authors:  Edward J Calabrese; Edward J Stanek; Marc A Nascarella; George R Hoffmann
Journal:  Int J Toxicol       Date:  2008 Sep-Oct       Impact factor: 2.032

10.  Update on NCI in vitro drug screen utilities.

Authors:  S L Holbeck
Journal:  Eur J Cancer       Date:  2004-04       Impact factor: 9.162

  10 in total
  4 in total

Review 1.  Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue.

Authors:  Julio C Rojas; Aleksandra K Bruchey; F Gonzalez-Lima
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

2.  Generic Hockey-Stick Model for Estimating Benchmark Dose and Potency: Performance Relative to BMDS and Application to Anthraquinone.

Authors:  Kenneth T Bogen
Journal:  Dose Response       Date:  2010-10-21       Impact factor: 2.658

3.  A method to evaluate hormesis in nanoparticle dose-responses.

Authors:  Marc A Nascarella; Edward J Calabrese
Journal:  Dose Response       Date:  2012-05-28       Impact factor: 2.658

4.  Omeprazole inhibits proliferation and modulates autophagy in pancreatic cancer cells.

Authors:  Andrej Udelnow; Andreas Kreyes; Stefan Ellinger; Katharina Landfester; Paul Walther; Thomas Klapperstueck; Johannes Wohlrab; Doris Henne-Bruns; Uwe Knippschild; Peter Würl
Journal:  PLoS One       Date:  2011-05-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.